Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.5M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
5.39M
-
Shares change
-
-553K
-
Total reported value, excl. options
-
$3.28M
-
Value change
-
-$9.12K
-
Number of buys
-
17
-
Number of sells
-
-31
-
Price
-
$0.55
Significant Holders of FibroBiologics, Inc. - Common Stock (FBLG) as of Q3 2025
67 filings reported holding FBLG - FibroBiologics, Inc. - Common Stock as of Q3 2025.
FibroBiologics, Inc. - Common Stock (FBLG) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.39M shares
of 37.5M outstanding shares and own 14.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.23M shares), Yorkville Advisors Global, LP (510K shares), MILLENNIUM MANAGEMENT LLC (446K shares), BlackRock, Inc. (440K shares), LANDSCAPE CAPITAL MANAGEMENT, L.L.C. (350K shares), GTS SECURITIES LLC (309K shares), Cascade Financial Partners, LLC (298K shares), GEODE CAPITAL MANAGEMENT, LLC (289K shares), CITADEL ADVISORS LLC (211K shares), and Cerity Partners LLC (126K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.